Literature DB >> 11286966

Exclusion of a cholesterol analog from the cholesterol-rich phase in model membranes.

L M Loura1, A Fedorov, M Prieto.   

Abstract

Vesicles of phosphatidylcholine/cholesterol mixtures show a wide composition range with coexistence of two fluid phases, the 'liquid disordered' (cholesterol-poor) and 'liquid ordered' (cholesterol-rich) phases. These systems have been widely used as models of membranes exhibiting lateral heterogeneity (membrane domains). The distributions of two fluorescent probes (a fluorescent cholesterol analog, NBD-cholesterol, and a lipophilic rhodamine probe, octadecylrhodamine B) in dimyristoylphosphatidylcholine/cholesterol vesicles were studied, at 30 degrees C and 40 degrees C. The steady-state fluorescence intensity of both probes decreases markedly with increasing cholesterol concentration, unlike the fluorescence lifetimes. The liquid ordered to liquid disordered phase partition coefficients K(p) were measured, and values much less than unity were obtained for both probes, pointing to preference for the cholesterol-poor phase. Globally analyzed time-resolved energy transfer results confirmed these findings. It is concluded that, in particular, NBD-cholesterol is not a suitable cholesterol analog and its distribution behavior in phosphatidylcholine/cholesterol bilayers is in fact opposite to that of cholesterol.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286966     DOI: 10.1016/s0005-2736(01)00269-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

1.  Effect of membrane characteristics on phase separation and domain formation in cholesterol-lipid mixtures.

Authors:  Veena Pata; Nily Dan
Journal:  Biophys J       Date:  2004-11-12       Impact factor: 4.033

2.  Effect of membrane microheterogeneity and domain size on fluorescence resonance energy transfer.

Authors:  Kevin B Towles; Angela C Brown; Steven P Wrenn; Nily Dan
Journal:  Biophys J       Date:  2007-04-20       Impact factor: 4.033

3.  Correlated fluorescence-atomic force microscopy of membrane domains: structure of fluorescence probes determines lipid localization.

Authors:  James E Shaw; Raquel F Epand; Richard M Epand; Zaiguo Li; Robert Bittman; Christopher M Yip
Journal:  Biophys J       Date:  2005-12-16       Impact factor: 4.033

Review 4.  Membrane microheterogeneity: Förster resonance energy transfer characterization of lateral membrane domains.

Authors:  Luís M S Loura; Fábio Fernandes; Manuel Prieto
Journal:  Eur Biophys J       Date:  2009-10-21       Impact factor: 1.733

Review 5.  Fluorescent membrane probes' behavior in lipid bilayers: insights from molecular dynamics simulations.

Authors:  Luís M S Loura; J P Prates Ramalho
Journal:  Biophys Rev       Date:  2009-09-04

6.  Phase Behavior of Planar Supported Lipid Membranes Composed of Cholesterol and 1,2-Distearoyl-sn-Glycerol-3-Phosphocholine Examined by Sum-Frequency Vibrational Spectroscopy.

Authors:  Jin Liu; John C Conboy
Journal:  Vib Spectrosc       Date:  2009-05-26       Impact factor: 2.507

7.  Membrane lipid rafts are disturbed in the response of rat skeletal muscle to short-term disuse.

Authors:  Alexey M Petrov; Violetta V Kravtsova; Vladimir V Matchkov; Alexander N Vasiliev; Andrey L Zefirov; Alexander V Chibalin; Judith A Heiny; Igor I Krivoi
Journal:  Am J Physiol Cell Physiol       Date:  2017-03-08       Impact factor: 4.249

8.  Nanodomains can persist at physiologic temperature in plasma membrane vesicles and be modulated by altering cell lipids.

Authors:  Guangtao Li; Qing Wang; Shinako Kakuda; Erwin London
Journal:  J Lipid Res       Date:  2020-01-21       Impact factor: 5.922

Review 9.  Quantification of protein-lipid selectivity using FRET.

Authors:  Luís M S Loura; Manuel Prieto; Fábio Fernandes
Journal:  Eur Biophys J       Date:  2010-03       Impact factor: 1.733

10.  Synthesis and spectral properties of cholesterol- and FTY720-containing boron dipyrromethene dyes.

Authors:  Zaiguo Li; Robert Bittman
Journal:  J Org Chem       Date:  2007-10-03       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.